Highlights from the Podium and In the News
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Publication of the one year follow-up results from our Phase 1/2a clinical trial in dry age-related macular degeneration - In a Special Issue of Translational Vision Science & Technology (tvst)
THE STEM CELLAR Sometimes a cold stare is a good thing
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
Read the latest blog post (or listen on Spotify) profiling our program on THE STEM CELLAR, The Official Blog of CIRM, California's Stem Cell Agency.
University of California Santa Barbara - The Current
Publication of One-Year Follow-Up Results of Phase 1/2a Clinical Trial
University of California Santa Barbara - The Current
In an article for UCSB - The Current, Britney Pennington and Lincoln Johnson discuss how novel cryopreservation methods enable long-term storage and worldwide distribution of a cellular therapy for age-related macular degeneration.
Publication in Scientific Reports
Publication in Science and Translational Medicine
University of California Santa Barbara - The Current
In a paper published in the journal Scientific Reports, RPT scientists in collaboration with colleagues at the University of California Santa Barbara and the University of Southern California report a novel cryopreservation technique that facilitates long-term storage of RPT’s CPCB-RPE1 ocular implants. This technique will greatly enhance the ability to widely distribute the implants and increase the number AMD patients that are able to receive the treatment.
Publication in Science and Translational Medicine
Publication in Science and Translational Medicine
Publication in Science and Translational Medicine
Publication of preliminary results from our Phase 1/2a clinical trial in dry age-related macular degeneration - The cover story in Science Translational Medicine
AARP - Medical Breakthroughs of 2020
Publication in Science and Translational Medicine
Publication in Science and Translational Medicine
AARP highlights RPT Study participant in: Saving Their Health and Ours. Medical Breakthroughs of 2020
First Step
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
A video produced by the Roski Eye Institute - highlighting the first implant procedure
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
A participant in our clinical trial shares her story.
Vision for the Future: Stem Cell Therapy for Eye Disease
Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant
Vision for the Future: Stem Cell Therapy for Eye Disease
RPT co-founder Dr. Dennis Clegg describes the recent strategies to develop a regenerative patch for the treatment of age-related macular degeneration by developing a cellular therapy using stem cells.
TEDx talk - Stemming Vision Loss with Stem Cells
TEDx talk - Stemming Vision Loss with Stem Cells
Vision for the Future: Stem Cell Therapy for Eye Disease
TEDx talk - Stemming Vision Loss with Stem Cells- RPT co-founder Dr. Dennis Clegg
Featured in National Geographic
TEDx talk - Stemming Vision Loss with Stem Cells
Featured in National Geographic
Why There’s New Hope About Ending Blindness
The Story of Sight
TEDx talk - Stemming Vision Loss with Stem Cells
Featured in National Geographic
Highlighted in the documentary Story of Sight